Shandong Lukang Pharmaceutical Co., Ltd. Class ASSE: 600789

"Shandong Lukang Pharmaceutical Co., Ltd."Special Report on the Deposit, Management and Actual Use of Raised Funds

Aug 29, 2026 · Issued by Shandong Lukang Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Special Report on the Deposit, Management and Actual Use of Raised Funds

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Shandong Lukang Pharmaceutical Co., Ltd. Class A

"Shandong Lukang Pharmaceutical Co., Ltd."Announcement on the Controlled Subsidiary Obtaining the Supplementary Application Approval Notice for Crisaborole Ointment and Becoming the Marketing Authorization Holder of the DrugAug 20
"Shandong Lukang Pharmaceutical Co., Ltd."Announcement on Obtaining Notice of Approval for Marketing of Chemical API for Lenvatinib MesylateAug 13
"Shandong Lukang Pharmaceutical Co., Ltd."Announcement on Obtaining Drug Registration CertificateAug 8
"Shandong Lukang Pharmaceutical Co., Ltd."Announcement on Investment in Construction of Green Bio‑manufacturing Project by Wholly‑owned SubsidiaryAug 6

All Shandong Lukang Pharmaceutical Co., Ltd. Class A news releases